Therapeutics / Biotech / BioTech / Drugs / Drug / Boston / Boston blog main / Boston top stories / National blog main / anti-HIV prophylactic therapy / bill gates / BostonVC / Drug Delivery / drug-delivery pump / Exenatide / exome / FDA / Financing / funding / Gates Foundation / Grant / HIV / Intarcia / Intarcia Therapeutics / ITCA 650 / Life Science / Life Sciences / Melinda Gates / New Drug Application / pump / Series EE / The Bill & Melinda Gates Foundation / Type 2 Diabetes / Venture Capital / Venture Funding

Gates Foundation Sends $140M to Intarcia for HIV Version of Pump

Posted on: Dec 29, 2016   |   Posted by: Biotech Mag

Gates Foundation Sends $140M to Intarcia for HIV Version of Pump

Intarcia Therapeutics, a Boston biotech that's developing a tiny, implantable drug-delivery pump for type 2 diabetes , is now broadening its focus to HIV backed by as much as...

Continue reading ...